Pancreatic Cancer Research

ResearcherPeking University First HospitalNo recent work listed

Kun Xie

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper

Papers 3

  1. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer. Co-author DOI 10.1007/s10620-013-2673-2↗
  2. Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells. Co-author DOI 10.1007/s10620-012-2036-4↗
  3. [Regulatory mechanisms of Hedgehog signaling pathway for epithelial-mesenchymal transition in pancreatic cancer cells]. Co-author PMID 22340649↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chang-fu Qin · 3 shared papers, 2011–2013 · strength 0.11
  2. Xiaodong Tian · 3 shared papers, 2011–2013 · strength 0.11
  3. Kun Hao · 3 shared papers, 2011–2013 · strength 0.11
  4. Zhigang Chang · 2 shared papers, 2011–2012 · strength 0.06
  5. Yinmo Yang · 2 shared papers, 2011–2012 · strength 0.06
  6. Yinmo Yang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.